메뉴 건너뛰기




Volumn 24, Issue 2, 2001, Pages 308-315

Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; PLACEBO; ROSIGLITAZONE;

EID: 0035146515     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.24.2.308     Document Type: Article
Times cited : (277)

References (31)
  • 2
    • 0027512732 scopus 로고
    • Role of insulin resistance in human disease (syndrome X): An expanded definition
    • (1993) Annu Rev Med , vol.44 , pp. 121-131
    • Reaven, G.M.1
  • 4
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    • (1998) Lancet , vol.352 , pp. 837-853
  • 6
    • 0032511566 scopus 로고    scopus 로고
    • Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
    • (1998) Lancet , vol.352 , pp. 854-865
  • 10
    • 0018602014 scopus 로고
    • Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance
    • (1979) Diabetes , vol.28 , pp. 1039-1057
  • 16
    • 0005169502 scopus 로고    scopus 로고
    • United Kingdom Prospective Diabetes Study 24: A 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy
    • (1998) Ann Intern Meal , vol.128 , pp. 165-175
  • 22
    • 0032727659 scopus 로고    scopus 로고
    • Thiazolidinediones: A new class of antidiabetic drugs
    • (1999) Diabet Med , vol.16 , pp. 179-192
    • Day, C.1
  • 28


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.